Mohamad Bassam Sonbol

Suparno Roy Chowdhury, Manan Roy Choudhury, Tejas Anvekar et al.

We study clinical trial table reasoning, where answers are not directly stored in visible cells but must be reasoned from semantic understanding through normalization, classification, extraction, or lightweight domain reasoning. Motivated by the observation that current LLM approaches often suffer from "bad reasoning" under implicit planning assumptions, we focus on settings in which the model must recover implicit attributes such as therapy type, added agents, endpoint roles, or follow-up status from partially observed clinical-trial tables. We propose SCOPE (Structured Clinical hybrid Planning for Evidence retrieval in clinical trials), a multi-LLM planner-based framework that decomposes the task into row selection, structured planning, and execution. The planner makes the source field, reasoning rules, and output constraints explicit before answer generation, reducing ambiguity relative to direct prompting. We evaluate SCOPE on 1,500 hybrid reasoning questions over oncology clinical-trial tables against zero-shot, few-shot, chain-of-thought, TableGPT2, Blend-SQL, and EHRAgent. Results show that explicit multi-LLM planning improves accuracy for reasoning-based questions while offering a stronger accuracy-efficiency tradeoff than heavier agentic baselines. Our findings position clinical trial reasoning as a distinct table understanding problem and highlight hybrid planner-based decomposition as an effective solution

Suparno Roy Chowdhury, Tejas Anvekar, Manan Roy Choudhury et al.

Clinicians exploring oncology trial repositories often need ad-hoc, multi-constraint queries over biomarkers, endpoints, interventions, and time, yet writing SQL requires schema expertise. We demo FD-NL2SQL, a feedback-driven clinical NL2SQL assistant for SQLite-based oncology databases. Given a natural-language question, a schema-aware LLM decomposes it into predicate-level sub-questions, retrieves semantically similar expert-verified NL2SQL exemplars via sentence embeddings, and synthesizes executable SQL conditioned on the decomposition, retrieved exemplars, and schema, with post-processing validity checks. To improve with use, FD-NL2SQL incorporates two update signals: (i) clinician edits of generated SQL are approved and added to the exemplar bank; and (ii) lightweight logic-based SQL augmentation applies a single atomic mutation (e.g., operator or column change), retaining variants only if they return non-empty results. A second LLM generates the corresponding natural-language question and predicate decomposition for accepted variants, automatically expanding the exemplar bank without additional annotation. The demo interface exposes decomposition, retrieval, synthesis, and execution results to support interactive refinement and continuous improvement.

Naman Ahuja, Saniya Mulla, Muhammad Ali Khan et al.

We present EviSearch, a multi-agent extraction system that automates the creation of ontology-aligned clinical evidence tables directly from native trial PDFs while guaranteeing per-cell provenance for audit and human verification. EviSearch pairs a PDF-query agent (which preserves rendered layout and figures) with a retrieval-guided search agent and a reconciliation module that forces page-level verification when agents disagree. The pipeline is designed for high-precision extraction across multimodal evidence sources (text, tables, figures) and for generating reviewer-actionable provenance that clinicians can inspect and correct. On a clinician-curated benchmark of oncology trial papers, EviSearch substantially improves extraction accuracy relative to strong parsed-text baselines while providing comprehensive attribution coverage. By logging reconciler decisions and reviewer edits, the system produces structured preference and supervision signals that bootstrap iterative model improvement. EviSearch is intended to accelerate living systematic review workflows, reduce manual curation burden, and provide a safe, auditable path for integrating LLM-based extraction into evidence synthesis pipelines.